United Therapeutics Corporation (UTHR): Price and Financial Metrics

United Therapeutics Corporation (UTHR): $236.24

2.18 (+0.93%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add UTHR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#15 of 360

in industry

UTHR Price/Volume Stats

Current price $236.24 52-week high $261.54
Prev. close $234.06 52-week low $204.44
Day low $234.16 Volume 191,775
Day high $240.00 Avg. volume 432,521
50-day MA $232.23 Dividend yield N/A
200-day MA $229.57 Market Cap 11.12B

UTHR Stock Price Chart Interactive Chart >


United Therapeutics Corporation (UTHR) Company Bio


United Therapeutics develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension. The company was founded in 1996 and is based in Silver Spring, Maryland.


UTHR Latest News Stream


Event/Time News Detail
Loading, please wait...

UTHR Latest Social Stream


Loading social stream, please wait...

View Full UTHR Social Stream

Latest UTHR News From Around the Web

Below are the latest news stories about UNITED THERAPEUTICS CORP that investors may wish to consider to help them evaluate UTHR as an investment opportunity.

15 Undervalued Defensive Stocks For 2024

In this article, we discuss the 15 undervalued defensive stocks for 2024. To skip the detailed overview of the market and defensive stocks, go directly to the 5 Undervalued Defensive Stocks For 2024. Defensive stocks are shares of companies that remain relatively stable during economic downturns as opposed to cyclical stocks. Defensive stocks usually outperform […]

Yahoo | December 24, 2023

Director Nilda Mesa Sells Shares of United Therapeutics Corp

On December 19, 2023, Director Nilda Mesa sold 605 shares of United Therapeutics Corp (NASDAQ:UTHR), according to a recent SEC Filing.

Yahoo | December 22, 2023

Insider Sell: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)

United Therapeutics Corp (NASDAQ:UTHR) has recently witnessed an insider sell that has caught the attention of investors and market analysts.

Yahoo | December 19, 2023

Investors in United Therapeutics (NASDAQ:UTHR) have seen stellar returns of 143% over the past five years

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Yahoo | December 19, 2023

Catalent (CTLT) Up 4.1% Since Last Earnings Report: Can It Continue?

Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 15, 2023

Read More 'UTHR' Stories Here

UTHR Price Returns

1-mo -0.70%
3-mo 7.97%
6-mo 5.28%
1-year 3.48%
3-year 13.85%
5-year 131.52%
YTD 7.44%
2023 -20.93%
2022 28.70%
2021 42.35%
2020 72.33%
2019 -19.12%

Continue Researching UTHR

Want to see what other sources are saying about UNITED THERAPEUTICS Corp's financials and stock price? Try the links below:

UNITED THERAPEUTICS Corp (UTHR) Stock Price | Nasdaq
UNITED THERAPEUTICS Corp (UTHR) Stock Quote, History and News - Yahoo Finance
UNITED THERAPEUTICS Corp (UTHR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!